TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
邵幼雲SHAO, YU-YUN
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
83筆
51
Li-Chun Lu, Yu-Yun Shao, Soa-Yu Chan, Chih-Hung Hsu, Ann-Lii Cheng. Clinical Characteristics of Advanced Hepatocellular Carcinoma Patients with Prolonged Survival in the Era of Anti-angiogenic Targeted-therapy. Anticancer Research 2014 Feb; 34: 1047-1052#
52
Yu-Yun Shao, Chih-Horng Wu, Li-Chun Lu, Soa-Yu Chan, Yu-Yi Ma, Feng-Chu Yen, Chih-Hung Hsu, Ann-Lii Cheng. Prognosis of Patients with Advanced Hepatocellular Carcinoma Who Failed First-Line Systemic Therapy. J Hepatol 2014 Feb; 60: 313-318#
53
Wei-Li Ma, Feng-Ming Hsu, Sun-Hsin Kuo, Yu-Yun Shao. Beta-Human Chorionic Gonadotropin Secreting Germinoma Refractory to Multi-Modality Treatment. J Cancer Res Pract 2014 Jan; 30: 53-58
54
Zhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, Yu-Yun Shao, Yi-Chun Yeh, Raymond NC Kuo, Chih-Hung Hsu, James CH Yang, Ann-Lii Cheng, Mei-Shu Lai. Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size. PLoS One 2013 Nov; 8: e80276#
55
Yu-Yun Shao, Yung-Lin Chang, Chung-Yi Huang, Chih-Hung Hsu, Ann-Lii Cheng. The Germline BIM Deletion Polymorphism Is Not Associated with Treatment Efficacy of Sorafenib for Patients with Advanced Hepatocellular Carcinoma. Oncology 2013 Nov; 85: 312-316#
56
Yu-Yun Shao*, Po-Chin Liang*, Yao-Ming Wu, Chun-Chieh Huang, Kai-Wen Huang, Jason Chia-Hsien Cheng, Chih-Hung Hsu, Chiun Hsu, Ann-Lii Cheng, Zhong-Zhe Lin. A Pilot Study of Hepatic Arterial Infusion of Chemotherapy for Patients with Advanced Hepatocellular Carcinoma Who Have Failed Antiangiogenic Therapy. Liver International 2013 Oct; 33: 1413-1419 (*co-first authors)#
57
Chih-Hung Hsu, Yoon Koo Kang, Tsai-Shen Yang, Chia-Tung Shun, Yu-Yun Shao, Wu-Chou Su, Jennifer Sandoval-Tan, Tzeon-Jye Chiou, Kate Jin, Chiun Hsu, Ann-Lii Cheng. Bevacizumab plus erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: a multicenter phase II study. Oncology 2013 Jul; 85:44-52#
58
Yu-Yun Shao, Chih-Hung Hsu, Ann-Lii Cheng. Predictive Biomarkers of Antiangiogenic Therapy for Advanced Hepatocellular Carcinoma: Where Are We? Liver Cancer 2013 Apr; 2:93-107#
59
Yi-Hsin Liang, Yu-Yun Shao, Jia-Yi Chen, Po-Chin Liang, Ann-Lii Cheng, Zhong-Zhe Lin. Modern Prospection for Hepatic Arterial Infusion Chemotherapy in Malignancies with Liver Metastases. International Journal of Hepatology 2013 Apr; Article ID 141590
60
Li-Chun Lu*, Yu-Yun Shao*, Raymond NC Kuo, Zhong-Zhe Lin, Yi-Chun Yeh, Wen-Yi Shau, Chih-Hung Hsu, Ann-Lii Cheng, Mei-Shu Lai. Hospital Volume of Percutaneous Radiofrequency Ablation is Closely Associated with Treatment Outcomes for Patients with Hepatocellular Carcinoma. Cancer 2013 Mar;119: 1210-1216 (*co-first authors)#
